mircera
roche registration gmbh - metoxi-polietilenglicol epoetina beta - anemia; kidney failure, chronic - preparaciones antianémicas - treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in adult patients (see section 5. treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in paediatric patients from 3 months to less than 18 years of age who are converting from another erythropoiesis stimulating agent (esa) after their haemoglobin level was stabilised with the previous esa (see section 5.
retacrit 1000 ui 6 xeringues precarregades 0,3 ml
retacrit 2000 ui 6 xeringues precarregades 0,6 ml
retacrit 3000 ui 6 xeringues precarregades 0,9 ml
retacrit 4000 ui 6 xeringues precarregades 0,4 ml
retacrit 5000 ui 6 xeringues precarregades 0,5 ml
retacrit 6000 ui 6 xeringues precarregades 0,6 ml
retacrit 8000 ui 6 xeringues precarregades 0,8 ml
retacrit 10000 ui 6 xeringues precarregades 1 ml
retacrit 40000 ui 1 xeringa precargada 1 ml